Head and Neck Cancer Trial, Recruiting NCT05442957 Sponsor: Medical University of South Carolina Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT05442957
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are over 18 years old at the time of signing the consent form
  • People who have been diagnosed with a type of cancer affecting the mouth, throat, voice box, nose or sinuses, salivary glands, or skin of the face or neck (confirmed by a lab test)
  • People who have had surgery aimed at curing their cancer, with or without additional treatments such as radiation or chemotherapy, and with or without reconstructive surgery
  • People who finished their main cancer treatment no more than 12 months before joining the study, and at least 6 weeks before joining — note that being on additional immunotherapy after the main treatment does not disqualify someone
  • People who are free of cancer at the time of joining the trial (having certain slow-growing or low-risk conditions, such as some skin cancers, low-risk thyroid cancer, or untreated low-risk prostate cancer, would not automatically prevent someone from joining — confirm with trial site)
  • People who do not have any major head or neck surgery planned during the study period, as determined by the treating surgeon
  • People who are willing to be randomly assigned to either of the two programs being studied
  • People who score 22 or above on a questionnaire called the IMAGE-HN (confirm with trial site for details on this assessment)

Who may not be able to join:

  • People who are not able to speak or read English
  • People who are currently receiving ongoing psychological therapy for any condition and are not willing to pause that therapy for the duration of the trial
  • People living with a severe mental illness that would prevent them from taking part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 843-792-0719

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
14 February 2023
Est. completion
30 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

IMAGE-HN

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov